Vijaya Diagnostic Centre — 360° view

Vijaya Diagnostic Centre, a company in the Healthcare Service Provider industry, reported revenue of ₹255 crore and net profit of ₹59 crore for the September 2026 quarter.

Vijaya Diagnostic Centre (NSE: VIJAYA) closed at ₹1,572.30 on 20 Nov 2026, up 55.5% over the past year. Its market capitalisation is ₹16,194 crore and it trades at 79.5 times earnings.

Share price
₹1,572.30 (20 Nov 2026)
Market cap
₹16,194 Cr (20 Nov 2026)
P/E
79.51 (20 Nov 2026)
Revenue
₹255 Cr (September 2026 quarter)
Net profit
₹59 Cr (September 2026 quarter)
ROCE
20.5% (FY26)
ROE
18.9% (FY26)
Book value
₹103 (FY26)
Dividend yield
0.13% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,593.60 / ₹848.00 (20 Nov 2026)
1-year return
55.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: VIJAYA

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.